Retinal ganglion cell-derived vesicles: A new path to neuroprotection
Molecular Therapy · 2026-10 · 34 (10) · 5627-5629
DOI: 10.1016/j.ymthe.2026.08.030 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Therapy, 2026-10. Verfasst von Kun-Che Chang. Beteiligte Einrichtung: Department of Ophthalmology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA; Department of Neurobiology, University of Pittsburgh S…. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NEI NIH HHS, National Eye Institute, Research to Prevent Blindness.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Ophthalmology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA; Department of Neurobiology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA; Department of Bioengineering,…
Förderung
- NEI NIH HHS
- National Eye Institute
- Research to Prevent Blindness
Zitieren
APA
Chang, K. C. (2026). Retinal ganglion cell-derived vesicles: A new path to neuroprotection. Molecular Therapy, 34(10), 5627-5629. https://doi.org/10.1016/j.ymthe.2026.08.030
Vancouver
Chang KC. Retinal ganglion cell-derived vesicles: A new path to neuroprotection. Molecular Therapy. 2026;34(10):5627-5629. doi:10.1016/j.ymthe.2026.08.030
BibTeX
@article{Chang2026,
author = {Chang, Kun-Che},
title = {Retinal ganglion cell-derived vesicles: A new path to neuroprotection},
journal = {Molecular Therapy},
year = {2026},
volume = {34},
number = {10},
pages = {5627--5629},
doi = {10.1016/j.ymthe.2026.08.030}
}
EUVIMED